Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy.
Luca IelasiBernardo StefaniniFabio ContiMatteo TonniniRaffaella TortoraGiulia MaginiRodolfo SaccoTiziana PressianiFranco TrevisaniFrancesco Giuseppe FoschiPiscaglia FabioAlessandro GranitoFrancesco TovoliPublished in: Current oncology (Toronto, Ont.) (2024)
Intermediate-stage subclassification systems maintain their predictive value also in the setting of systemic therapy. The Bolondi and Wang criteria showed the highest accuracy. AFP > 400 ng/mL enhances the performance of these systems.